Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Liver Cancer|January 7, 2016
Effectiveness of Sorafenib in Patients with Transcatheter Arterial Chemoembolization (TACE) Refractory and Intermediate-Stage Hepatocellular CarcinomaTadaaki Arizumi, Kazuomi Ueshima, Tomohiro Minami, et al.
Oncology|December 16, 2016
Contrast-Enhanced Tissue Harmonic Imaging versus Phase Inversion Harmonic Sonographic Imaging for the Delineation of Hepatocellular CarcinomasMasashi Kono, Yasunori Minami, Mina Iwanishi, et al.
Cancers|December 11, 2025
No Correlation Between Proteinuria and Renal Function in Patients with Unresectable Hepatocellular Carcinoma Treated with Atezolizumab Plus Bevacizumab: ARISE StudyKazuomi Ueshima, Naoshi Nishida, Satoru Hagiwara, et al.
Digestive Diseases (Basel, Switzerland)|October 22, 2015
Early Viral Response Predicts the Efficacy of Antiviral Triple Therapy with Simeprevir, Peg-Interferon and Ribavirin in Patients Infected with Hepatitis C Virus Genotype 1Naoshi Nishida, Mina Iwanishi, Tomohiro Minami, et al.
Digestive Diseases (Basel, Switzerland)|October 22, 2015
Hepatic DNA Methylation Is Affected by Hepatocellular Carcinoma Risk in Patients with and without Hepatitis VirusNaoshi Nishida, Mina Iwanishi, Tomohiro Minami, et al.
Liver Cancer|June 19, 2024
Two Distinct Characteristics of Immune Microenvironment in Human Hepatocellular Carcinoma with Wnt/β-Catenin MutationsTomoko Aoki, Naoshi Nishida, Yutaka Kurebayashi, et al.
Digestive Diseases (Basel, Switzerland)|October 18, 2016
Clinical Factors Predicting the Effect of Tolvaptan for Refractory Ascites in Patients with Decompensated Liver CirrhosisHirokazu Chishina, Satoru Hagiwara, Naoshi Nishida, et al.
Digestive Diseases (Basel, Switzerland)|October 22, 2015
Real-Life Clinical Practice with Sorafenib in Advanced Hepatocellular Carcinoma: A Single-Center Experience Second AnalysisTadaaki Arizumi, Kazuomi Ueshima, Mina Iwanishi, et al.
Scientific Reports|April 13, 2022
Role of phlebotomy in the treatment of liver damage related to erythropoietic porphyriaSatoru Hagiwara, Naoshi Nishida, Hiroshi Ida, et al.
Oncology|November 20, 2015
Validation of a Modified Substaging System (Kinki Criteria) for Patients with Intermediate-Stage Hepatocellular CarcinomaTadaaki Arizumi, Kazuomi Ueshima, Mina Iwanishi, et al.
Pageof 6